Troglitazone inhibits progesterone production in porcine granulosa cells
Troglitazone inhibits progesterone production in porcine granulosa cells
复制标题
DOI:
10.1210/en.139.12.4962
复制
发表时间:
1998-12-01
期刊:
影响因子:
4.8
通讯作者:
Urban, RJ
中科院分区:
文献类型:
--
作者:
Gasic, S;Bodenburg, Y;Urban, RJ
Troglitazone (a thiazolidinedione that improves insulin resistance) lowers elevated androgen concentrations in women with polycystic ovarian syndrome. In this study, we assessed the direct effects of troglitazone on steroidogenesis in porcine granulosa cells. Troglitazone inhibited progesterone production in a dose- and time-dependent manner (earliest effects at 4 h, maximum at 24 h) without affecting cell viability. Progesterone production was also inhibited by troglitazone in the presence of 25-hydroxycholesterol, indicating that the drug does not affect intracellular cholesterol transport. Troglitazone also inhibited FSH- and forskolin-stimulated progesterone secretion. The reduced progesterone production was accompanied by narked elevations of pregnenolone concentrations, suggesting inhibition of 3 beta-hydroxysteroid dehydrogenase (BP-HSD). The activity of 3 beta-HSD in troglitazone-treated granulosa cells was decreased by more than 60%, compared with controls after 24 h. Troglitazone did not. affect aromatase activity in porcine granulosa cells. In summary, troglitazone has direct effects on porcine granulosa cell steroidogenesis. The drug specifically inhibits 3 beta-HSD activity, resulting in impaired progesterone production. The clinical relevance of this direct in vitro effect on steroidogenesis needs further investigation.